For example, decreased levels of cystatin C have been correlated with better survival rates, as seen in a recent study for the prognosis and evaluation of renal cell carcinoma patients [72], while conversely enhanced levels of cystatin C were observed in patients with melanoma and CRC [48]. This evidence concerns the gene CST3 and melanoma.